HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$4.83
Day range
$4.78 - $5.10
Year range
$3.35 - $5.64
Market cap
42.78M USD
Avg Volume
6.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Motley Fool
11 hours ago
The Nasdaq Sell-Off Has Made These 3 Great Growth Stocks Even Better Buys
0.95%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.75M | 52.10% |
Operating expense | 2.21M | -2.27% |
Net income | 515.00K | 145.18% |
Net profit margin | 6.64 | 129.68% |
Earnings per share | — | — |
EBITDA | 1.30M | 553.83% |
Effective tax rate | 1.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.81M | 289.14% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 26.41M | — |
Shares outstanding | 8.91M | — |
Price to book | 1.62 | — |
Return on assets | — | — |
Return on capital | 3.71% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 515.00K | 145.18% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1982
Headquarters
Website
Employees
77
